Guadalupe Cervantes

Statistics

Publications

Citations

1.5K

H-Index

Active since

1985

Affiliations

Asociacion Para Evitar la Ceguera en México Hospital Dr. Luis Sánchez Bulnes(Current)

Institute for Social Security and Services for State Workers

Guadalupe Cervantes is an author at Asociacion Para Evitar la Ceguera en México Hospital Dr. Luis Sánchez Bulnes specializing in medicine, oncology, and capecitabine-based therapy.

Publications per year

1985–2017

Publications

Superior Survival With Capecitabine Plus Docetaxel Combination Therapy in Anthracycline-Pretreated Patients With Advanced Breast Cancer: Phase III Trial Results

Joyce O’Shaughnessy, David Miles, Svetislava J. Vukelja et al. · Journal of Clinical Oncology · 2002 · 1.1K citations

Medicine, Oncology, Pharmacology +14

Squamous cell carcinoma of the conjunctiva: clinicopathological features in 287 cases

Guadalupe Cervantes, Abelardo A. Rodríguez, Alfredo Gómez Leal · Canadian Journal of Ophthalmology · 2002 · 126 citations

Medicine, Oncology, Pathology +14

Inhibition of surgically induced miosis and prevention of postoperative macular edema with nepafenac

Guadalupe Cervantes · Clinical ophthalmology · 2009 · 58 citations · Full text

Medicine, Perioperative Medicine, Pharmacotherapy +12

Survival Benefit with Capecitabine/Docetaxel Versus Docetaxel Alone: Analysis of Therapy in a Randomized Phase III Trial

David Miles, Svetislava J. Vukelja, Vladimir Moiseyenko et al. · Clinical Breast Cancer · 2004 · 54 citations

Medicine, Oncology, Pharmacology +9

Capecitabine (X) and taxanes in patients (pts) with anthracycline-pretreated metastatic breast cancer (MBC): Sequential vs. combined therapy results from a MOSG randomized phase III trial

Laura Torrecillas, Sylvia A. Reyes, María Teresa Ramírez et al. · Journal of Clinical Oncology · 2006 · 52 citations

Medicine, Oncology, Pharmacology +17

1–5 of 9